EnviTec Biogas AG
- WKN: A0MVLS
- ISIN: DE000A0MVLS8
- Land: Deutschland
Nachricht vom 06.07.2021 | 16:28
EnviTec Biogas Annual General Meeting 2021: Advanced biofuels - a new promising field of activity
DGAP-News: EnviTec Biogas AG
/ Key word(s): AGM/EGM/Dividend
EnviTec Biogas Annual General Meeting 2021
Lohne/Saerbeck, 6 July 2021 - The shareholders of EnviTec Biogas AG (ISIN: DE000A0MVLS8) today honoured the positive performance of the company at the second digital Annual General Meeting. In 2020, the full-service biogas provider rigorously continued its business development and achieved a very positive consolidated result in spite of the ongoing COVID-19 pandemic. "We owe it above all to the know-how of our employees as well as to our integrated corporate strategy that we did not have to resort to short-time work or take advantage of government aid programmes in the second year of the pandemic and were even able to achieve one of the best results in the history of our company," said CEO Olaf von Lehmden.
Chief Financial Officer Jörg Fischer and Chief Technology Officer Jürgen Tenbrink also expressed their confidence that the company will be able to defend its position as the leading integrated full-service biogas provider also in 2021. This is essentially attributable to the development of a new business field, advanced biogas fuels, which has been accelerated by the acquisition of BioEnergie Güstrow, Europe's largest biogas plant. "Thanks to the ambitiously implemented Renewable Energy Directive RED II, significant greenhouse gas savings can now be achieved in the German fuel mix after 30 years of standstill, although they still fall short of the overall political targets," von Lehmden continued.
In their presentations, the three Executive Board members analysed the business trend of 2020 in detail. "It is clearly visible that we have grown continuously over the past years and have further increased our profitability in the process. In the past fiscal year 2020, we were even able to further increase the record EBITDA of the previous year once again. This was achieved not least thanks to the greatly increased momentum in the Plant Construction segment," CFO Jörg Fischer said. For the current fiscal year 2021, the Executive Board projects slightly higher total output and earnings before taxes of EUR 17-19 million.
At the Annual General Meeting, the Executive Board and the Supervisory Board were discharged from liability by a large majority. The other items on the agenda were also clearly approved. These include the resolution to again distribute EUR 14.85 million from EnviTec Biogas AG's accumulated profit of EUR 23.72 million, which corresponds to a dividend of EUR 1 per entitled share. The shareholders attending the Annual General Meeting represented 85.39 % of the share capital.
|Company:||EnviTec Biogas AG|
|Phone:||+49 (0) 44 42 - 80 65 0|
|Fax:||+49 (0) 44 42 - 80 65 103|
|Listed:||Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange|
|EQS News ID:||1215853|
|End of News||DGAP News Service|
GBC im Fokus
IGEA Pharma N.V. Realignment to CBD extraction
The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.
Der AKTIONÄR News
02. Dezember 08:25 Salesforce: Der Zahlen-Schock sitzt tief
02. Dezember 08:28 Volkswagen: Neuer Kurstreiber für die Aktie?!
02. Dezember 08:30 Zalando: Das macht jetzt Hoffnung
02. Dezember 08:30 Hot-Stock der Woche: Das Netflix fürs Kinderzimmer
02. Dezember 09:00 Auch das noch: Apple warnt vor nachlassender iPhone-Nachfrage
News im Fokus
Symrise verlängert Vorstandsvertrag von Dr. Heinz-Jürgen Bertram vorzeitig bis 2025
01. Dezember 2021, 15:38
FY 2020/2021 Financial Results
16. Dezember 2021
Original-Research: Bio-Gate AG (von GBC AG): Kaufen
02. Dezember 2021